Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

I1. Adult Vaccines

Poster Session: Adult Vaccines

(P-22) Implementing Patient-Reported Outcomes in Community Screening Programs: Results from the 2023 Southern Hemisphere Influenza Season

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
Location: Virtual

    Co-Author(s)

  • JE

    Jessie Edwards, Dr.

    Discipline of General Practice, University of Adelaide, Australia
    Adelaide, South Australia, Australia

  • JM

    Jocelyn Moyes, Dr.

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
    Johannesburg, Gauteng, South Africa

    • Co-Author(s)

  • ED

    Erica Dueger, Dr.

    Sanofi Vaccines, Lyon France
    Lyon, Rhone-Alpes, France

    • Co-Author(s)

  • NS

    Nigel Stocks, Prof. Dr.

    Discipline of General Practice, University of Adelaide, Australia
    A, South Australia, Australia

  • MM

    Mvuyo Makhasi, Dr.

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
    Johannesburg, Gauteng, South Africa

  • SS

    Sheena Sullivan, Dr.

    Department of Infectious Diseases, University of Melbourne
    Melbourne, Victoria, Australia

  • SW

    Sibongile Walaza, Dr.

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
    Johannesburg, Gauteng, South Africa

  • MC

    Monique Chilver, MPH

    Discipline of General Practice, University of Adelaide, Australia
    Adelaide, South Australia, Australia

  • LA

    Lana Allen, n/a

    Discipline of General Practice, University of Adelaide, Australia
    Adelaide, South Australia, Australia

  • DB

    Daniel Blakeley, n/a

    Discipline of General Practice, University of Adelaide, Australia
    Adelaide, South Australia, Australia

  • FM

    Fahima Moosa, n/a

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
    Johannesburg, Gauteng, South Africa

  • AV

    Anne Von Gottberg, Prof. Dr.

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
    Johannesburg, Gauteng, South Africa

  • NW

    Nicole Wolter, MD

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
    Johannesburg, Gauteng, South Africa

  • MD

    Mignon Du Plessis, Dr.

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service, Johannesburg, South Africa
    Johannesburg, Gauteng, South Africa

  • CC

    Cheryl Cohen, n/a

    Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa.
    Johannesburg, Gauteng, South Africa

  • RO

    Richard Osborne, Prof. Dr.

    Measured Solutions for Health Pty. Ltd., Alphington, Australia
    Alphington, Victoria, Australia

    • Presenting Author(s)

  • José Bartelt-Hofer, Dr. (he/him/his)

    Project Lead, Global Health Economics and Outcomes Research
    Sanofi Vaccines, Lyon France
    Lyon, Rhone-Alpes, France